The research team, led by Alex Olateju Adjagba and colleagues spanning health economics institutions and African Union health bodies, assembled a panel dataset covering 2002 through 2023 for all 54 African Union member states, drawing on expenditure records from the World Health Organization and the World Bank. Rather than relying on stated budget allocations, which can diverge sharply from what governments actually disburse, the researchers constructed an expenditure-based proxy for the Abuja commitment. This distinction matters because approved budgets in many low-income countries are routinely revised downward, executed incompletely, or supplemented by off-budget donor flows that complicate any simple accounting of domestic priority.

The methodological architecture of the study is unusually layered. The authors distinguished three levels of achievement: observed attainment in a given year, first attainment at any point in the record, and sustained attainment across consecutive years. To characterize how long countries took to cross the threshold for the first time, they applied Kaplan-Meier survival analysis, a technique borrowed from clinical epidemiology that estimates the probability of an event occurring over time, paired with Weibull parametric models that flexibly describe the underlying hazard of attainment. Country-specific linear trends were then fitted to each nation’s spending history and extrapolated forward, generating projected benchmark-crossing years through 2063 for the 51 countries with complete data series.

The projections are sobering. In the primary trend specification, 42 of those 51 countries, or 82.4 percent, were classified as off track to reach the 15 percent benchmark by 2063, the horizon year of the African Union’s Agenda 2063 development framework. For the 48 countries that had never previously attained the target, the median adjusted conditional probability of achieving first attainment at any point between 2023 and 2063 was just 7.9 percent, with an interquartile range running from 4.6 percent to 13.3 percent. In plain terms, even the most optimistic quartile of countries faced less than a one-in-seven chance of ever crossing the line under business-as-usual fiscal behavior.

Why has the target proven so elusive? One answer lies in what the authors describe as strong persistence in health’s budget share. Using a system generalized method of moments estimator, a dynamic panel technique designed to handle feedback loops between past and present spending decisions, the team estimated a lag coefficient of 0.821, with a 95 percent confidence interval of 0.635 to 1.006. This means that a country’s health expenditure share in any given year is overwhelmingly determined by its share in the previous year. Fiscal priorities, once established, tend to lock in. Countries that start with health claiming a small slice of the budget rarely break out of that equilibrium on their own, and external shocks, elections, or donor campaigns produce only temporary deviations rather than lasting structural shifts.

The study also probed what the Abuja target actually buys. Using country and year fixed-effects models, which strip away time-invariant national characteristics and continent-wide shocks, the researchers examined the relationship between overall government health prioritization and spending on two critical fronts: primary health care and immunization. The results showed that higher prioritization was associated with higher domestic government expenditure per capita on primary health care, suggesting that when governments push health’s budget share upward, frontline services do benefit. The association with total immunization expenditure per capita, however, was not statistically significant, a finding that likely reflects the dominant role of external financing, particularly Gavi, the Vaccine Alliance, in funding immunization programs across much of the continent.

These nuances carry real policy weight. The Abuja Declaration, signed in April 2001 amid the HIV/AIDS crisis, was conceived as a political accountability device: a simple, memorable number that civil society, parliaments, and citizens could hold their governments to. The new analysis does not dismiss that function. The authors argue that the 15 percent target remains politically useful as an accountability signal. But they caution that the share itself is a means, not an end. A country can nominally meet the benchmark while still spending too little per person to deliver basic care, particularly if its overall economy and tax base are small. Conversely, a country below 15 percent may nonetheless achieve meaningful per capita health spending if fiscal capacity is strong.

That reframing points toward a different set of policy levers. The study’s authors argue that efforts should concentrate on improving public health expenditure per capita, expanding fiscal capacity through domestic revenue mobilization, strengthening budget execution so that allocated funds actually reach facilities, deepening financial protection so households are not impoverished by medical bills, and extending service coverage. Budget execution deserves particular emphasis: the gap between approved allocations and actual expenditure is a chronic weakness in many African public financial management systems, and an expenditure-based evaluation like this one captures the consequences of that gap in a way that allocation-based scorecards cannot.

The timing of the analysis is significant for another reason. With donor health financing under increasing pressure and many African countries approaching or crossing the thresholds at which they graduate from concessional support, the question of domestic priority has moved from the margins of development policy to its center. The study’s finding that expenditure shares are so persistent suggests that waiting for organic change is not a strategy. Deliberate institutional mechanisms, such as legal health financing floors, ring-fenced budget lines, and transparent expenditure tracking, may be required to shift countries off trajectories that currently point away from the benchmark for decades to come.

For a continent whose population is projected to roughly double by 2050 and whose burden of disease is shifting toward noncommunicable conditions even as infectious threats persist, the arithmetic of underinvestment compounds quickly. The Abuja Declaration was an aspiration born of crisis, and twenty-four years on, the evidence assembled by Adjagba and colleagues shows how rarely aspiration has translated into sustained fiscal commitment. Whether the next two decades look different will depend less on the number 15 itself than on whether governments can convert political pledges into executed budgets, executed budgets into per capita resources, and per capita resources into the primary health care and financial protection that their citizens increasingly demand.

Subject of Research: Progress toward the Abuja Declaration target of allocating 15 percent of government budgets to health in African countries

Article Title: Beyond aspiration: An expenditure-based evaluation of progress towards the Abuja Declaration target and implications for domestic health financing in Africa

Article References: Adjagba, A. O., Novignon, J., Nonvignon, J., Owusu, R., Lemango, E., Fogstad, H., Ngongo, N., Kaseya, J., & Laryea-Adjei, G. (2026). Beyond aspiration: An expenditure-based evaluation of progress towards the Abuja Declaration target and implications for domestic health financing in Africa. PLOS Global Public Health, 6(10), e0007423. https://doi.org/10.1371/journal.pgph.0007423

Image Credits: AI Generated

DOI: 10.1371/journal.pgph.0007423

Keywords: Abuja Declaration, health financing, African Union, government health expenditure, primary health care, immunization, fiscal capacity, budget execution, PLOS Global Public Health, Kaplan-Meier analysis, system GMM, domestic resource mobilization

South Asia is home to nearly a quarter of humanity, and its demographic trajectory is changing rapidly. Countries such as India, Sri Lanka, Bangladesh, Nepal, and their neighbors have experienced dramatic gains in life expectancy over the past several decades, driven by improvements in sanitation, vaccination coverage, maternal health, and the treatment of infectious disease. Those gains, however, come with a demographic consequence: the proportion of older adults is climbing steadily. Populations that once had very young age structures are now entering a period in which chronic, non-communicable diseases such as cardiovascular disease, diabetes, cancer, and dementia account for a growing share of the disease burden. Because older adults consume disproportionately more health care than younger age groups, the question of whether aging drives public health spending is not academic; it goes to the heart of fiscal planning for governments with limited resources and large populations.

Despite the obvious stakes, the authors note that relatively few studies have examined the impact of population aging on government health expenditure in the South Asian context specifically. Much of the existing literature on health spending determinants has focused on high-income countries in Europe, East Asia, and North America, where aging is far more advanced and health accounts are more complete. South Asian countries present a distinctive analytical challenge: they are aging from a much younger baseline, their public health spending per capita remains among the lowest in the world, and out-of-pocket expenditure dominates total health financing in much of the region. Understanding how aging interacts with public spending in this setting requires methods capable of handling messy, interdependent panel data, and this is precisely where the new study makes its methodological contribution.

The researchers drew their data from the World Development Indicators, one of the most widely used and carefully curated global statistical databases, compiled by the World Bank. Their dependent variable was the log of domestic general government health expenditure per capita, a measure that captures spending by governments within each country rather than external aid or private out-of-pocket payments. The key explanatory variable was the log of the population aged 65 and above. To isolate the effect of aging from other forces that shape health spending, the team included a set of control variables: population density, the total size of the labor force, per capita gross domestic product, unemployment, and the number of physicians per 1,000 people. Each of these controls reflects a plausible channel through which economic and demographic conditions could influence how much governments spend on health per citizen.

Panel data of this kind, covering multiple countries over more than two decades, are notorious for statistical complications that can distort naive estimates. Three problems stand out. Heteroscedasticity means the variance of the errors differs across countries and over time, which undermines standard confidence intervals. Cross-sectional dependence means that shocks in one country, such as a regional financial crisis or a pandemic, simultaneously affect neighboring countries, violating the assumption that observations are independent across units. Autocorrelation means that errors in one year are correlated with errors in the next, reflecting the fact that health spending evolves gradually rather than randomly. Ignoring any of these issues can produce estimates that appear statistically significant when they are, in fact, artifacts of the data structure.

To confront these challenges head-on, the authors employed two complementary estimation strategies. The first was the Driscoll-Kraay standard error method, a technique specifically designed for panel models with cross-sectional dependence. Rather than assuming independence across countries, Driscoll-Kraay standard errors are computed from the cross-sectional averages of the moment conditions at each point in time, producing estimates that remain valid even when the errors are correlated across countries, heteroscedastic, and autocorrelated. The second approach was the panel corrected standard error method, which similarly adjusts inference for panel-specific heteroscedasticity and contemporaneous correlation. The fact that both methods yielded consistent results strengthens the credibility of the central finding: the association between the older population share and per capita government health expenditure is positive and statistically significant.

Perhaps the most sophisticated element of the study is its treatment of endogeneity, the problem that arises when the presumed cause and effect influence each other. Aging plausibly drives health spending upward, but the reverse is also conceivable: better-funded public health systems extend life expectancy, which in turn enlarges the elderly population. A simple regression that ignores this two-way feedback can produce biased estimates. To address this, the researchers applied a simultaneous equation model estimated by three-stage least squares, a classical econometric technique that models the mutual dependence between variables explicitly. By instrumenting the endogenous relationship across the system of equations, the three-stage least squares approach allows the authors to disentangle the direction of influence and confirm that the aging-spending link survives even under this more demanding specification. The consistency of results across Driscoll-Kraay, panel corrected standard errors, and the simultaneous equation framework constitutes a robust triangulation of evidence.

The substantive conclusion is striking in its clarity: health expenditure and population aging reinforce each other. As the population aged 65 and above grows, governments spend more on health per capita, and that spending, in turn, contributes to the longevity that enlarges the older population. This feedback loop is neither inherently good nor bad, but it has profound fiscal consequences. On one hand, rising public health investment is exactly what the Sustainable Development Goals call for, particularly the target of universal health coverage. On the other hand, if spending growth is driven reactively by the escalating costs of treating advanced chronic disease in aging populations, health budgets may become increasingly consumed by expensive late-stage care rather than by prevention and primary care that deliver better outcomes at lower cost.

The authors draw a direct policy lesson from their findings: because aging and health expenditure reinforce one another, policymakers in South Asia should adopt sustainable financing mechanisms and preventive care strategies to manage costs while ensuring health longevity. In practical terms, this could mean expanding insurance pools and risk-sharing arrangements before the aging wave peaks, investing in screening and management of hypertension and diabetes in middle age, strengthening geriatric and primary care infrastructure, and building long-term care systems before demand outstrips capacity. Countries in the region have a narrow demographic window, sometimes described as a dividend period, in which the working-age population is still large relative to dependents. Using that window to build resilient, prevention-oriented health systems could mean the difference between aging as a manageable transition and aging as a fiscal shock.

The study is not without limitations, which the authors acknowledge candidly. Data unavailability prevented them from incorporating other potentially important factors, and they note that future research can extend the analysis using the same advanced methodological toolkit while accounting for additional determinants. Nevertheless, the contribution is significant precisely because the South Asian region has been understudied in this literature. As the global population ages faster than at any point in human history, the experience of South Asia, where aging is unfolding against a backdrop of low baseline health spending and enormous population scale, will be a critical test case for whether public health systems worldwide can grow sustainably alongside the people they serve. This research offers both a warning and a roadmap: the demographic tide is already lifting health expenditure, and the time to shape how governments respond is now.

Subject of Research: The relationship between population aging and government health expenditure in South Asian countries

Article Title: Does aging matter? Mapping the government health expenditure in South Asian countries

Article References: Does aging matter? Mapping the government health expenditure in South Asian countries. (n.d.). https://doi.org/10.1186/s12913-026-15545-4

Image Credits: AI Generated

DOI: 10.1186/s12913-026-15545-4

Keywords: population aging, government health expenditure, South Asia, health economics, Driscoll-Kraay, panel data, three-stage least squares, sustainable development goals, health financing, demography, preventive care, health policy